Analysis and monitoring of drug therapy in a patient with peptic ulcer complicated by infection:A case report  

作　　者：Yan-Ping Gou Yue Huang Li Chen Wei Zheng Yun-Hua Zheng 

机构地区：[1]The Second People’s Hospital of Meishan City&Renshou County People’s Hospital,Meishan 620500,Sichuan Province,China [2]Quality Evaluation and Medical Record Management,The Affiliated Hospital of Southwest Jiaotong University&The Third People's Hospital of Chengdu,Chengdu 610000,Sichuan Province,China [3]Patriotic Health Campaign,Qionglai City Health Bureau,Chengdu 610000,Sichuan Province,China

出　　处：《World Journal of Clinical Cases》2024年第8期1530-1535,共6页世界临床病例杂志

摘　　要：BACKGROUND The role of primary-level medical pharmacists in medical institutions in China is limited;therefore,it is necessary to explore the role of pharmacists in the process of drug treatment.CASE SUMMARY A Chinese pharmacist participated in the complete treatment of a patient with a duodenal ulcer.The rationale for drug treatment was evaluated,and adjustments were made to the antacid and anti-infective regimen,as well as the dose and frequency of administration.Body temperature,routine blood examination,and adverse drug reactions were strictly monitored.During treatment,the pharmacist recommended anti-infective therapy with ampicillin-sulbactam,which effectively controlled the infection.Additionally,the pharmacist suggested changing famotidine to lansoprazole for acid suppression and gastroprotective treatment,combined with Chinese patent medicine such as Kangfuxin Liquid.This is the first case report of a pharmacist in primary-level medical institutions adjusting drug use for patients with duodenal ulcer and pulmonary infection.CONCLUSION A pharmacist participated in the treatment process,provided individualized medication adjustment,and achieved good clinical results.

关 键 词：Ampicillin-sulbactam FAMOTIDINE LANSOPRAZOLE Kangfuxin Liquid Chinese pharmacist Case report 

分 类 号：R575.2[医药卫生—消化系统] R573.1[医药卫生—内科学]